Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Vardi

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Clinical Transplantation|August 7, 2018
Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantationEleni Gavriilaki, Ioanna Sakellari, Ioannis Batsis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2013
IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implicationsAnna Vardi, Andreas Agathangelidis, Lesley-Ann Sutton, et al.
Journal of Clinical Apheresis|November 6, 2018
Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center studyIoanna Sakellari, Eleni Gavriilaki, Ioannis Batsis, et al.
International Journal of Hematology|October 6, 2019
Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host diseaseEleni Gavriilaki, Ioanna Sakellari, Ioanna Karafoulidou, et al.
Transplantation Proceedings|August 21, 2021
Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-DiseaseEleni Gavriilaki, Ioanna Sakellari, Thomas Chatzikonstantinou, et al.
International Journal of Molecular Sciences|April 28, 2023
Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A ReceptorDionysios Vythoulkas, Ioanna Lazana, Christos Kroupis, et al.
International Journal of Molecular Sciences|November 25, 2023
Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and OutcomesApostolia Papalexandri, Eleni Gavriilaki, Anna Vardi, et al.
Transplantation Proceedings|February 17, 2024
Open-Label Randomized Controlled Study of Ciprofloxacin vs Rifaximin as Neutropenia Prophylaxis in Allogeneic Hematopoietic Stem Cell TransplantationEleni Gavriilaki, Despina Mallouri, Evgenia Laspa, et al.
International Journal of Molecular Sciences|December 29, 2020
Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell TransplantationEleni Gavriilaki, Ioanna Sakellari, Panagiota Anyfanti, et al.
Journal of Neurology|May 16, 2019
Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortalityIoanna Sakellari, Eleni Gavriilaki, Sotirios Papagiannopoulos, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Clinical Transplantation|August 7, 2018
Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantationEleni Gavriilaki, Ioanna Sakellari, Ioannis Batsis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2013
IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implicationsAnna Vardi, Andreas Agathangelidis, Lesley-Ann Sutton, et al.
Journal of Clinical Apheresis|November 6, 2018
Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center studyIoanna Sakellari, Eleni Gavriilaki, Ioannis Batsis, et al.
International Journal of Hematology|October 6, 2019
Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host diseaseEleni Gavriilaki, Ioanna Sakellari, Ioanna Karafoulidou, et al.
Transplantation Proceedings|August 21, 2021
Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-DiseaseEleni Gavriilaki, Ioanna Sakellari, Thomas Chatzikonstantinou, et al.
International Journal of Molecular Sciences|April 28, 2023
Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A ReceptorDionysios Vythoulkas, Ioanna Lazana, Christos Kroupis, et al.
International Journal of Molecular Sciences|November 25, 2023
Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and OutcomesApostolia Papalexandri, Eleni Gavriilaki, Anna Vardi, et al.
Transplantation Proceedings|February 17, 2024
Open-Label Randomized Controlled Study of Ciprofloxacin vs Rifaximin as Neutropenia Prophylaxis in Allogeneic Hematopoietic Stem Cell TransplantationEleni Gavriilaki, Despina Mallouri, Evgenia Laspa, et al.
International Journal of Molecular Sciences|December 29, 2020
Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell TransplantationEleni Gavriilaki, Ioanna Sakellari, Panagiota Anyfanti, et al.
Journal of Neurology|May 16, 2019
Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortalityIoanna Sakellari, Eleni Gavriilaki, Sotirios Papagiannopoulos, et al.
Pageof 5